Utilizing
Social Media
for
New Product Commercialization




                                1
Who Are We?




              2
Today We’ll Discuss
     Presentation Context

     Pharma & Social Media

     Why Social media should be on Your Radar Screen
      for New Product Commercialization

     Demonstrate the Tactical Role of Social Media
      in New Product Commercialization
Background




             4
Background




             5
Background




             6
Background



 The Physician
 still has to
 prescribe it!




                 7
Pharma & Social Media

               Primary Target for Digital Communication




Across Health Digital Survey EMEA 2011                    8
Pharma & Social Media




Social Media and Healthcare, EPG Health Media, Summer 2011   9
Pharma & Social Media

                                % Utilization of Digital Tools




Across Health Digital Survey EMEA 2011                           10
Pharma & Social Media

                                  Physicians Don’t Want to Talk to You
                            100
  Influence % online HCPs




                            80                                    Consulting with Colleagues in Person
                                               Offline Journals
                                             Online Journals
                                                                       HCPs-only Portal (Social Networks)
                            60


                            40


                            20                      Sales Reps
                                         Pharma
                                         Websites

                                    20              40            60             80            100
                                           Weekly/Daily Use % online HCPs

                                                                                                            11
Pharma & Social Media
               Toronto Diabetes KOL Network

                                              Physicians are
                                              already
                                              organized into
                                              communities
                                              and are actively
                                              engaged in
                                              conversations




Source: Lnx Pharma                                               12
Pharma & Social Media


  Re-invent the wheel




  Work with existing
  interpersonal
  communication network


                          13
Pharma & Social Media: Success Factors

  Talking                      Listening
  Push                         Pull

  Product Brand                Range Brand

  Selling Pills                Outcomes
  Initiating                   Participating
                                               14
Definition




             15
Definition – What is Social Media?


   Social media is the term commonly given to
   Internet and mobile-based channels and
   tools that allow users to interact with each
   other and share opinions and content. As
   the name implies, social media involves the
   building of communities or networks and
   encouraging participation and engagement.



                                                  16
Why Should Social Media be on the Radar Screen?




                                        Difficult Cases

                                                 Experience with
                                                 New Medications




Physician Participation in Peer-to-Peer Social Media Sites - Why Is It Less Than Expected?   17
Pharma Marketing Oct 12 2011
Why Should Social Media be on the Radar Screen?

Pre-launch

 Improve the quality
 of the market
 research




                                             18
Social Media: Impact Pre-Launch

     Customer segment research - Clinical Value Criteria

             Model the Market

             Confirm Revenue Forecast

             Product Positioning

     Pre-launch Promotion




                                                            19
Why Should Social Media be on the Radar Screen?

Post launch
Mitigate the rapidly
decreasing effectiveness
of the Sales Rep channel.


Physician Engagement


Product Diffusion

                                             20
Social Media: Impact Post Launch

     Increase Reach and Frequency

     Contract the Sales Cycle

     Increase Speed of Diffusion

     Enhance the Clinical / Brand Relevancy

     Manage the Physician Experience Trial

     Capture Real-time Campaign Management Data

                                                   21
Hypothetical Case Study




    Schizophrenia
                          22
Hyper-competition



               Generic Atypicals




                    4
                              23
Hyper-competition



               Branded Atypicals




                    2
                              24
Hyper-competition



               Generic Typicals




                    5
                              25
Hyper-competition



               Immediate Future




                    3
                             26
Social Media Strategy: Product Launch

 Engagement
     Getting involved
     and returning



Influence
     Early Adopters on
     Early and late Majority

                                        27
Something to Talk About!
Something to talk about




                              28
Something to Talk About




                          29
Performance on the 4 Pillars of Positioning


   Efficacy                      Equal
   Safety                        Equal

   Tolerability                  Advantage

   Price                         Disadvantage

                                              30
Opportunity




              Treatment
              Failure Rate
              up to 75%




                             31
Why Psychiatrists Prescribe



                              High Importance




                              Medium Importance




                                                  32
APPLICATION of SOCIAL MEDIA




                              33
Pre-launch: Customer Research



 Traditional
 Market Research
 Inadequate for
 Hyper-competition




                                34
Pre-launch: Customer Research

     Serial market research
      participants

     All brands have access to the
      same data

     “35,000 foot” view of market –
      not actionable

     9/10 product launch with
      category leader positioning


                                       35
Pre-launch: Customer Research

     Switch from a COMMERCIAL
      to an ACADEMIC research
      model

     Engage the Community in a
      discussion about the Clinical
      Value of currently available
      products




                                      36
Pre-launch: Customer Research


                          How do I impact
                       prescribing behaviour?




       I know What                                 I don’t know
           Is Rx’d                                 Why it is Rx’d
     (The Behaviour)                            @ Customer Segment
                                                 (The Motivation)




                                                                     37
Pre-launch: Customer Research
                       Clinical Value Analysis




                           Research Lead
   Deliverable to                                    Deliverable to
     Physicians                                         Pharma
 Benchmarking Data                               Segment Level Data

                            Present Findings
                                   &
                    Facilitate Discussion / Debate

                                                                      38
39
Pre-launch: Pre-launch Promotion



 Alternative to...




                                   40
Pre-launch: Pre-launch Promotion




                                                                 Position
                                                                in Practice
                                      Capture Trial
                                      Criteria
                    Get Trial


                                                                         Ensure Trial
                                                                         Success




                                Review                Review
                                Options               Trial Progress


         Define the
         Clinical Problem



                                                                                        41
Pre-launch: Pre-launch Promotion

     Initiate a discussion about the role of weight gain in
      treatment non-adherence.


     Employ Clinical Value Analysis to review the failings of
      available drugs to solve the clinical problem




                                                                 42
Introducing a
solution to     What problem
schizophrenia
treatment
                do you solve?
non-adherence




                                43
Pre-launch: Pre-launch Promotion

     Move physicians through the early stages of adoption
      – missionary work

     Launch into Experience Trial phase - Rxs

     Gain access to No-see / Limited-see physicians

     Data to refine launch strategy

     Discover points of competitive entry




                                                             44
Post-launch: Manage the Experience Trial

   A model that
   describes how
   physicians adopt new
   treatment options




                                           45
Post-launch: Manage the Experience Trial




                                                                 Position
                                                                in Practice
                                      Capture Trial
                                      Criteria
                    Get Trial


                                                                         Ensure Trial
                                                                         Success




                                Review                Review
                                Options               Trial Progress


         Define the
         Clinical Problem



                                                                                        46
Post-launch: Manage the Experience Trial


                                 Self expression
                                 Communication
                                 Sharing
                                 Collaboration




                                                 47
Post-launch: Manage the Experience Trial

     Supplement Rep Activity

     Reach access challenged
      physicians

     Manage the most important
      phase of the product
      lifecycle

     Acquire forward looking data



                                           48
Pharma & Social Media




                        49
Utilizing Social Media for New Product Launch

Utilizing Social Media for New Product Launch

  • 1.
  • 2.
  • 3.
    Today We’ll Discuss  Presentation Context  Pharma & Social Media  Why Social media should be on Your Radar Screen for New Product Commercialization  Demonstrate the Tactical Role of Social Media in New Product Commercialization
  • 4.
  • 5.
  • 6.
  • 7.
    Background The Physician still has to prescribe it! 7
  • 8.
    Pharma & SocialMedia Primary Target for Digital Communication Across Health Digital Survey EMEA 2011 8
  • 9.
    Pharma & SocialMedia Social Media and Healthcare, EPG Health Media, Summer 2011 9
  • 10.
    Pharma & SocialMedia % Utilization of Digital Tools Across Health Digital Survey EMEA 2011 10
  • 11.
    Pharma & SocialMedia Physicians Don’t Want to Talk to You 100 Influence % online HCPs 80 Consulting with Colleagues in Person Offline Journals Online Journals HCPs-only Portal (Social Networks) 60 40 20 Sales Reps Pharma Websites 20 40 60 80 100 Weekly/Daily Use % online HCPs 11
  • 12.
    Pharma & SocialMedia Toronto Diabetes KOL Network Physicians are already organized into communities and are actively engaged in conversations Source: Lnx Pharma 12
  • 13.
    Pharma & SocialMedia Re-invent the wheel Work with existing interpersonal communication network 13
  • 14.
    Pharma & SocialMedia: Success Factors Talking Listening Push Pull Product Brand Range Brand Selling Pills Outcomes Initiating Participating 14
  • 15.
  • 16.
    Definition – Whatis Social Media? Social media is the term commonly given to Internet and mobile-based channels and tools that allow users to interact with each other and share opinions and content. As the name implies, social media involves the building of communities or networks and encouraging participation and engagement. 16
  • 17.
    Why Should SocialMedia be on the Radar Screen? Difficult Cases Experience with New Medications Physician Participation in Peer-to-Peer Social Media Sites - Why Is It Less Than Expected? 17 Pharma Marketing Oct 12 2011
  • 18.
    Why Should SocialMedia be on the Radar Screen? Pre-launch Improve the quality of the market research 18
  • 19.
    Social Media: ImpactPre-Launch  Customer segment research - Clinical Value Criteria  Model the Market  Confirm Revenue Forecast  Product Positioning  Pre-launch Promotion 19
  • 20.
    Why Should SocialMedia be on the Radar Screen? Post launch Mitigate the rapidly decreasing effectiveness of the Sales Rep channel. Physician Engagement Product Diffusion 20
  • 21.
    Social Media: ImpactPost Launch  Increase Reach and Frequency  Contract the Sales Cycle  Increase Speed of Diffusion  Enhance the Clinical / Brand Relevancy  Manage the Physician Experience Trial  Capture Real-time Campaign Management Data 21
  • 22.
    Hypothetical Case Study Schizophrenia 22
  • 23.
    Hyper-competition Generic Atypicals 4 23
  • 24.
    Hyper-competition Branded Atypicals 2 24
  • 25.
    Hyper-competition Generic Typicals 5 25
  • 26.
    Hyper-competition Immediate Future 3 26
  • 27.
    Social Media Strategy:Product Launch Engagement Getting involved and returning Influence Early Adopters on Early and late Majority 27
  • 28.
    Something to TalkAbout! Something to talk about 28
  • 29.
  • 30.
    Performance on the4 Pillars of Positioning Efficacy Equal Safety Equal Tolerability Advantage Price Disadvantage 30
  • 31.
    Opportunity Treatment Failure Rate up to 75% 31
  • 32.
    Why Psychiatrists Prescribe High Importance Medium Importance 32
  • 33.
  • 34.
    Pre-launch: Customer Research Traditional Market Research Inadequate for Hyper-competition 34
  • 35.
    Pre-launch: Customer Research  Serial market research participants  All brands have access to the same data  “35,000 foot” view of market – not actionable  9/10 product launch with category leader positioning 35
  • 36.
    Pre-launch: Customer Research  Switch from a COMMERCIAL to an ACADEMIC research model  Engage the Community in a discussion about the Clinical Value of currently available products 36
  • 37.
    Pre-launch: Customer Research How do I impact prescribing behaviour? I know What I don’t know Is Rx’d Why it is Rx’d (The Behaviour) @ Customer Segment (The Motivation) 37
  • 38.
    Pre-launch: Customer Research Clinical Value Analysis Research Lead Deliverable to Deliverable to Physicians Pharma Benchmarking Data Segment Level Data Present Findings & Facilitate Discussion / Debate 38
  • 39.
  • 40.
  • 41.
    Pre-launch: Pre-launch Promotion Position in Practice Capture Trial Criteria Get Trial Ensure Trial Success Review Review Options Trial Progress Define the Clinical Problem 41
  • 42.
    Pre-launch: Pre-launch Promotion  Initiate a discussion about the role of weight gain in treatment non-adherence.  Employ Clinical Value Analysis to review the failings of available drugs to solve the clinical problem 42
  • 43.
    Introducing a solution to What problem schizophrenia treatment do you solve? non-adherence 43
  • 44.
    Pre-launch: Pre-launch Promotion  Move physicians through the early stages of adoption – missionary work  Launch into Experience Trial phase - Rxs  Gain access to No-see / Limited-see physicians  Data to refine launch strategy  Discover points of competitive entry 44
  • 45.
    Post-launch: Manage theExperience Trial A model that describes how physicians adopt new treatment options 45
  • 46.
    Post-launch: Manage theExperience Trial Position in Practice Capture Trial Criteria Get Trial Ensure Trial Success Review Review Options Trial Progress Define the Clinical Problem 46
  • 47.
    Post-launch: Manage theExperience Trial Self expression Communication Sharing Collaboration 47
  • 48.
    Post-launch: Manage theExperience Trial  Supplement Rep Activity  Reach access challenged physicians  Manage the most important phase of the product lifecycle  Acquire forward looking data 48
  • 49.

Editor's Notes

  • #10 Worse than no-see rate
  • #14 Strategic listening.
  • #19 Products thathave failed9/10products have same positioning
  • #20 Confirm Forecast = Lilkihood to RxModel the Market – as changes occur in promotinal dynamicsConfirm Revenue ForecastProduct Positioning – offensive/flanking or Guerilla (9/10 products same positining)Pre-launch Promotion – Move docs thrugh first
  • #21 What do I need a rep forI know the studiesI don’t want biased informationApplication to my clinical situation
  • #22 Confirm Forecast = Lilkihood to Rx
  • #28 Metrics such as: Visits Unique commenters Time on Site Network size / quality Quantity / Quality of Commentary Thread size (how invested members are) Time with content (people reading or interacting with the content might be very interested, but quiet)Versus Reach / Frequency / Share of Voice
  • #29 Lots of information sources vying for physician`s attention
  • #33 comparable to Pfizer’s Geodon and Bristol-Myers’ Abilify, that is, less than Lilly’s ZyprexaAnd, unlike some other atypicals, Meltzer says that Latuda dosages donot require a lot of titration. “If you have an acutely ill patient, you can start them at 40 [mg] andit’s going to start to work within days, if not hours, based, of course, on how ill the patient is. Youdon’t have to experiment [with the dose] as you do with, say, quetiapine, where it is difficult to
  • #37 Engagement
  • #39 Research Lead = Engagment – Quanity and QualityDiscussion – Pharma and PhysiciansPeceotion is out of sync with medical factBenchmarking = JD Power rankingSaving Physician time
  • #40 Strategic listening
  • #43 What % see non-adherence as a clinical problemHow big a clinical problemPerception of clinical impactWhat % of patients affectedPerception of the role of weight gain
  • #46 Decide if they will a product to their armamentarium
  • #47 Scientifically validatedWillhappenwether you partiicpate of not.